March 14, 2023Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies January 24, 2023OmniaBio expands manufacturing footprint with second Hamilton location November 29, 2022Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology. November 7, 2022Resolution Therapeutics and CCRM sign collaboration agreement, with work to be executed at OmniaBio. October 6, 2022OmniaBio celebrates the beginning of construction. September 20, 2022NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada. May 31, 2022OmniaBio Inc. announces private investor. March 31, 2022Funding from Ontario Government for OmniaBio. March 31, 2022Invest Ontario Supports New Biomanufacturing Facility in Hamilton.